Evaluation for anthracnose resistance
The common bean genotypes were assessed as disease resistant or susceptible based on the severity of the infection on a 1–9 scale after 17 days. These were categorized into four reaction groups, namely highly resistant, moderately resistant, moderately susceptible, and susceptible, based on the percent disease index. Genotypes EC-398527, EC-400397, Hur 137, EC-398565, IC-258273, S 2, B 4, Utkarsh, P 2, Hur 15, EC-530898, BR 31, IC-260299, PDR 14, Amber, S 1, Arun, VL 63, IC-328372, IC-274530, B 12, B 6, S 6, EC-894826, P 32, EC-398591 were highly resistant. Moderately resistant genotypes include IC-243198, BR 8, IC-262837, BR 2, IC-361884, EC-400433, EC-531076, BR 22, P 6, BR 9, EC-500250, IC-260312, S 3, EC-500507, B 5, P 28, BR 6, IC-043562, B 7, EC-500308, BR 10, BR 1, B 9, IC-202274. Genotypes PL 1, EC-121013, BR 4, EC-398586, P 17, B 1, EC-500374, BR 15, P 29, P 15, EC-755305, P 14, P 33, EC-405220, IC-265932, S 4, EC-500305, VL 125, BR 3, S 5, P 5, BR 16, BR 30, IC-258276, BR 39, IC-260336, P 13, EC-13097, P 4 were moderately susceptible. BR 5, IC-199277, EC-400442, BR 18, BR 36, P 22, BR 7, Jawala, P 1, P 3 were susceptible (Fig. 1) (Table 4).
Table 4
Screening of common bean genotypes for anthracnose resistance
Genotype | Percent disease index | Disease reaction |
IC-243198 | 30.58% | MR |
EC-398527 | 10.84% | HR |
BR 8 | 33.33% | MR |
PL 1 | 37.03% | MS |
EC-121013 | 55.55% | MS |
IC-262837 | 27.77% | MR |
BR 2 | 33.17% | MR |
IC-361884 | 17.45% | MR |
BR 5 | 58.32% | S |
EC-400397 | 9.47% | HR |
Hur 137 | 6.17% | HR |
IC-199277 | 66.66% | S |
EC-398565 | 1.48% | HR |
IC-258273 | 6.17% | HR |
BR 4 | 41.66% | MS |
EC-400433 | 13.88% | MR |
EC-398586 | 37.03% | MS |
S 2 | 9.47% | HR |
EC-531076 | 33.33% | MR |
EC-400442 | 66.66% | S |
B 4 | 10.84% | HR |
P 17 | 55.55% | MS |
B 1 | 41.66% | MS |
BR 22 | 21.36% | MR |
EC-500374 | 55.55% | MS |
Utkarsh | 1.48% | HR |
BR 15 | 38.79% | MS |
P 6 | 32.40% | MR |
P 29 | 41.66% | MS |
BR 9 | 31.7% | MR |
BR 18 | 66.66% | S |
EC-500250 | 32.40% | MR |
P 15 | 37.03% | MS |
P 2 | 1.48% | HR |
IC-260312 | 22.22% | MR |
BR 36 | 66.66% | S |
EC-755305 | 37.05% | MS |
Hur 15 | 1.48% | HR |
P 14 | 36.10% | MS |
P 33 | 43.20% | MS |
EC-405220 | 54.16% | MS |
IC-265932 | 39.15% | MS |
EC-530898 | 10.10% | HR |
S 3 | 12.34% | MR |
S 4 | 37.03% | MS |
BR 31 | 10.84% | HR |
EC-500305 | 55.55% | MS |
IC-260299 | 10.10% | HR |
EC-500507 | 30.94% | MR |
PDR 14 | 6.17% | HR |
P 22 | 66.66% | S |
BR 7 | 58.32% | S |
P 28 | 20.05% | MR |
Jawala | 66.66% | S |
VL 125 | 37.03% | MS |
B 5 | 20.83% | MR |
Amber | 1.48% | HR |
S 1 | 1.48% | HR |
Arun | 6.17% | HR |
BR 6 | 31.74% | MR |
EC-398591 | 6.17% | HR |
VL 63 | 9.47% | HR |
IC-043562 | 24.69% | MR |
B 7 | 17.35% | MR |
EC-500308 | 16.20% | MR |
BR 3 | 39.68% | MS |
IC-328372 | 9.47% | HR |
S 5 | 37.05% | MS |
P 5 | 39.50% | MS |
BR 10 | 26.61% | MR |
BR 16 | 36.50% | MS |
BR 1 | 25.30% | MR |
IC-274530 | 10.7% | HR |
B 9 | 26.84% | MR |
BR 30 | 36.55% | MS |
IC-258276 | 55.55% | MS |
P 1 | 58.32% | S |
BR 39 | 47.00% | MS |
IC-260336 | 39.68% | MS |
IC-202274 | 31.74% | MR |
P 13 | 41.66% | MS |
B 12 | 6.47% | HR |
EC-13097 | 39.50% | MS |
B 6 | 1.48% | HR |
S 6 | 10.7% | HR |
P 3 | 66.66% | S |
P 4 | 39.68% | MS |
EC-894826 | 1.48% | HR |
P 32 | 1.48% | HR |
Where, HR: highly resistant; MR: moderately resistant, MS: moderately susceptible, S: susceptible |
Evaluation of genotypes for the Co-2 gene
The phenotypically screened resistant and moderately resistant genotypes were further evaluated for the presence of the Co-2 gene using the SCAreoli marker. PCR amplification with the SCAreoli marker gives a band size of 1.3 kb in all the genotypes. On digestion with the Dra I enzyme, a band size of 1 kb was produced in EC-500250, IC-274530, S 1, S 3, EC-398527, EC-398565, BR 8, EC-398591, and B 12 genotypes (Fig. 2).
Snp Identification
DNA sequences corresponding to the promoter region of the anthracnose resistant Co-2 gene were amplified from three resistant (B 12, IC-274530, EC-398591) and susceptible (IC-199277, BR 5, P 3) genotypes. The assembled forward and reverse sequences were used to determine regulatory motifs in the promoter database and candidate SNPs were identified. Twenty-three SNPs were obtained at positions 30, 32, 38, 39, 188, 223, 228, 326, 329, 475, 477, 481, 499, 503, 1017, 1019, 1024, 1369, 1373, 1469, 1471, 1472 and 1476. Fourteen SNPs (at positions 30, 32, 38, 39, 228, 326, 475, 477, 481, 499, 1017, 1471, 1472, 1476) were found to be strongly associated with disease resistance (Fig. 3) (Table 5).
Table 5
Identification of SNPs in the regulatory motifs
SNP | Position | Significant/ non-significant |
T/C | 30 | Significant |
G/A | 32 | Significant |
T/C | 38 | Significant |
A/C | 39 | Significant |
G/A | 188 | Non-significant |
T/C | 223 | Non-significant |
T/C | 228 | Significant |
C/A | 326 | Significant |
T/A | 329 | Non-significant |
T/G | 475 | Significant |
C/T | 477 | Significant |
G/A | 481 | Significant |
C/G | 499 | Significant |
A/G | 503 | Non-significant |
G/A | 1017 | Significant |
T/A | 1019 | Non-significant |
T/G | 1024 | Non-significant |
A/G | 1369 | Non-significant |
C/T | 1373 | Non-significant |
C/T | 1469 | Non-significant |
T/G | 1471 | Significant |
C/T | 1472 | Significant |
C/T | 1476 | Significant |
Development And Validation Of Allele-specific Marker
On aligning the sequences of resistant (IC-274530 (45); wild type) and susceptible (BR 5 (75); mutant) genotypes in dCAPS finder 2.0, a C/T mutation at 477 nucleotide position was observed. The SNP identified was converted into a CAPS marker by designing suitable primers and screening for corresponding restriction enzymes. The DNA fragment containing the SNP of interest was successfully amplified in IC-274530, BR 18, P 1, P 33, EC-500374, Arun, P 4, EC-398586, EC-400442, PL 1, BR 7, EC-894826, P 2, BR 36, EC-121013, VL 125, BR 39, P 29, IC-199277, S 5, P 14, P 5, B 1, BR 30, BR 5, EC-530898, IC-260336, P 22, EC-398527, EC-13097, VL 63, P 15, BR 4, BR 15, BR 16, BR 3, P 32, S 4, S 2, P 17, P 3, B 4, P 13 genotypes.
The Mse I digested PCR products from susceptible and moderately susceptible genotypes i.e. BR 18, P 1, P 33, EC-500374, P 4, EC-398586, EC-400442, PL 1, BR 7, BR 36, EC-121013, VL 125, BR 39, P 13, P 15, P 29, IC-199277, S 5, P 14, P 5, B 1, BR 30, BR 5, IC-260336, P 22, EC-13097, BR 4, BR 15, BR 3, S 4, P 17, P 3, BR 16 (200bp) but not from resistant genotypes i.e. IC-274530, Arun, EC-894826, P 2, EC-530898, EC-398527, VL 63, P 32, S 2, B 4 (290 bp) (Fig. 4).